AAAAAA
Results: 1-25/35
Authors:
Fauser, BCJM
Citation: Bcjm. Fauser, Publication ethics and research in human reproduction, HUM REP UPD, 7(4), 2001, pp. 357-357
Authors:
Fauser, BCJM
Citation: Bcjm. Fauser, Environmental effects on reproductive health, HUM REP UPD, 7(3), 2001, pp. 229-229
Authors:
De Jong, D
Van Hooren, EG
Macklon, NS
Mannaerts, BMJL
Fauser, BCJM
Citation: D. De Jong et al., Pregnancy and birth after GnRH agonist treatment for induction of final oocyte maturation in a woman undergoing ovarian stimulation for ICSI, using aGnRH antagonist (orgalutran/antagon) to prevent a premature LH surge: A case report, J AS REPROD, 18(1), 2001, pp. 30-33
Authors:
Laven, JSE
Imani, B
Eijkemasn, MJC
de Jong, FH
Fauser, BCJM
Citation: Jse. Laven et al., Absent biologically relevant associations between serum inhibin B concentrations and characteristics of polycystic ovary syndrome in normogonadotrophic anovulatory infertility, HUM REPR, 16(7), 2001, pp. 1359-1364
Authors:
Hohmann, FP
Laven, JSE
de Jong, FH
Eijkemans, MJC
Fauser, BCJM
Citation: Fp. Hohmann et al., Low-dose exogenous FSH initiated during the early, mid or late follicular phase can induce multiple dominant follicle development, HUM REPR, 16(5), 2001, pp. 846-854
Authors:
Laven, JSE
Lumbroso, S
Sultan, C
Fauser, BCJM
Citation: Jse. Laven et al., Dynamics of ovarian function in an adult woman with McCune-Albright syndrome, J CLIN END, 86(6), 2001, pp. 2625-2630
Authors:
Macklon, NS
Fauser, BCJM
Citation: Ns. Macklon et Bcjm. Fauser, Differential dose of antagonist (Ganirelix) relative to exogenous FSH - Reply, FERT STERIL, 76(5), 2001, pp. 1080-1080
Authors:
de Jong, D
Macklon, NS
Eijkemans, MJC
Mannaerts, BMJL
Bennink, HJTC
Fauser, BCJM
Citation: D. De Jong et al., Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon), FERT STERIL, 75(4), 2001, pp. 688-693
Authors:
Isojarvi, JIT
Tauboll, E
Pakarinen, AK
van Parys, J
Rattya, J
Harbo, HF
Dale, PO
Fauser, BCJM
Gjerstad, L
Koivunen, R
Knip, M
Tapanainen, JS
Citation: Jit. Isojarvi et al., Altered ovarian function and cardiovascular risk factors in valproate-treated women, AM J MED, 111(4), 2001, pp. 290-296
Authors:
Macklon, NS
Fauser, BCJM
Citation: Ns. Macklon et Bcjm. Fauser, Regulation of follicle development and novel approaches to ovarian stimulation for IVF, HUM REP UPD, 6(4), 2000, pp. 307-312
Authors:
Fauser, BCJM
Citation: Bcjm. Fauser, Appointment of new Editor-in-Chief, HUM REP UPD, 6(4), 2000, pp. I-I
Authors:
Berning, B
van Kuijk, C
Bennink, HJTC
Fauser, BCJM
Citation: B. Berning et al., Absent correlation between vaginal bleeding and oestradiol levels or endometrial morphology during tibolone use in early postmenopausal women, MATURITAS, 35(1), 2000, pp. 81-88
Authors:
van Heusden, AM
Killick, SR
Bennink, HJTC
Fauser, BCJM
Citation: Am. Van Heusden et al., Single monthly administration of the anti-progestagen Org 31710 in users of the 75 mu g desogestrel progestagen-only pill: effects on pituitary-ovarian activity, HUM REPR, 15(3), 2000, pp. 629-636
Authors:
Beckers, NGM
Laven, JSE
Eijkemans, MJC
Fauser, BCJM
Citation: Ngm. Beckers et al., Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization, HUM REPR, 15(1), 2000, pp. 43-49
Authors:
Macklon, NS
Fauser, BCJM
Citation: Ns. Macklon et Bcjm. Fauser, Impact of ovarian hyperstimulation on the luteal phase, J REPR FERT, 2000, pp. 101-108
Authors:
Imani, B
Eijkemans, MJC
de Jong, FH
Payne, NN
Bouchard, P
Giudice, LC
Fauser, BCJM
Citation: B. Imani et al., Free androgen index and leptin are the most prominent endocrine predictorsof ovarian response during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility, J CLIN END, 85(2), 2000, pp. 676-682
Authors:
Fauser, BCJM
Citation: Bcjm. Fauser, Follicle pool depletion: factors involved and implications, FERT STERIL, 74(4), 2000, pp. 629-630
Authors:
de Jong, D
Macklon, NS
Fauser, BCJM
Citation: D. De Jong et al., A pilot study involving minimal ovarian stimulation for in vitro fertilization: extending the "follicle-stimulating hormone window" combined with thegonadotropin-releasing hormone antagonist cetrorelix, FERT STERIL, 73(5), 2000, pp. 1051-1054
Authors:
Bouchard, P
Fauser, BCJM
Citation: P. Bouchard et Bcjm. Fauser, Gonadotropin-releasing hormone antagonist: new tools vs. old habits, FERT STERIL, 73(1), 2000, pp. 18-20
Authors:
Huisman, GJ
Fauser, BCJM
Eijkemans, MJC
Pieters, MHEC
Citation: Gj. Huisman et al., Implantation rates after in vitro fertilization and transfer of a maximum of two embryos that have undergone three to five days of culture, FERT STERIL, 73(1), 2000, pp. 117-122
Authors:
Beckers, NGM
Pieters, MHEC
Ramos, L
Zeilmaker, GH
Fauser, BCJM
Braat, DDM
Citation: Ngm. Beckers et al., Retrieval, maturation, and fertilization of immature oocytes obtained fromunstimulated patients with polycystic ovary syndrome, J AS REPROD, 16(2), 1999, pp. 81-86
Authors:
van Zonneveld, P
Scheffer, G
Koppeschaar, HPF
Fauser, BCJM
Broekmans, FJ
Velde, ERT
Citation: P. Van Zonneveld et al., Hormone patterns after induction of ovulation with clomiphene citrate: an age-related phenomenon, GYNECOL END, 13(4), 1999, pp. 259-265
Authors:
van Zonneveld, P
Koppeschaar, HPF
Habbema, JDF
Fauser, BCJM
te Velde, ER
Citation: P. Van Zonneveld et al., Diagnosis of subtle ovulation disorders in subfertile women with regular menstrual cycles: cost-effective clinical practice?, GYNECOL END, 13(1), 1999, pp. 42-47
Authors:
Berning, B
von Kuijk, C
Kuiper, JW
Bennink, HJTC
Fauser, BCJM
Citation: B. Berning et al., Increased loss of trabecular but not cortical bone density, 1 year after discontinuation of 2 years hormone replacement therapy with Tibolone, MATURITAS, 31(2), 1999, pp. 151-159
Authors:
Macklon, NS
Fauser, BCJM
Citation: Ns. Macklon et Bcjm. Fauser, Aspects of ovarian follicle development throughout life, HORMONE RES, 52(4), 1999, pp. 161-170